Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Escitalopram for depression after coronary artery bypass graft surgery
IRCT20140126016374N2Phase 3Completed
- Sponsor
- University of Social Welfare and Rehabilitation Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of escitalopram in major depressive disorder (MDD), sponsored by University of Social Welfare and Rehabilitation Sciences. Primary endpoints: Improvement in depressive disorder and Quality of life. Started Dec 2020; status: completed.
02
Drugs
escitalopram
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on IRCT20140126016374N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140126016374N2.